# Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI

> **NCT02640794** · PHASE4 · COMPLETED · sponsor: **Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec** · enrollment: 222 (actual)

## Conditions studied

- Aortic Valve Disease
- Myocardial Infarction
- Stroke
- Bleeding

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02640794
- **Lead sponsor:** Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-06
- **Final completion:** 2018-03
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02640794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02640794, "Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02640794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*